SERGLIFLOZIN NO FURTHER A MYSTERY

)-stereoisomer that is certainly, incredibly, a potent agonist of AR, as demonstrated by transcriptional assays supported by mobile imaging scientific tests. This duality was reproduced inside a series of novel compounds derived from your BMS-641988 scaffold. Coupled with in silico modeling studies, the outcomes tell an AR design that clarifies the